JP2025501239A5 - - Google Patents
Info
- Publication number
- JP2025501239A5 JP2025501239A5 JP2024539527A JP2024539527A JP2025501239A5 JP 2025501239 A5 JP2025501239 A5 JP 2025501239A5 JP 2024539527 A JP2024539527 A JP 2024539527A JP 2024539527 A JP2024539527 A JP 2024539527A JP 2025501239 A5 JP2025501239 A5 JP 2025501239A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antagonist
- subject
- age
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163295113P | 2021-12-30 | 2021-12-30 | |
| US63/295,113 | 2021-12-30 | ||
| PCT/US2022/082535 WO2023130010A1 (en) | 2021-12-30 | 2022-12-29 | Methods for attenuating atopic march by administering an il-4/il-13 antagonist |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025501239A JP2025501239A (ja) | 2025-01-17 |
| JP2025501239A5 true JP2025501239A5 (enExample) | 2026-01-09 |
Family
ID=85199428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024539527A Pending JP2025501239A (ja) | 2021-12-30 | 2022-12-29 | Ｉｌ－４／ｉｌ－１３アンタゴニストを投与することによってアトピーマーチを減弱する方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230220089A1 (enExample) |
| EP (1) | EP4457245A1 (enExample) |
| JP (1) | JP2025501239A (enExample) |
| KR (1) | KR20240135618A (enExample) |
| CN (1) | CN118355034A (enExample) |
| AU (1) | AU2022425608A1 (enExample) |
| CA (1) | CA3241374A1 (enExample) |
| IL (1) | IL313897A (enExample) |
| MX (1) | MX2024006053A (enExample) |
| WO (1) | WO2023130010A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118286417A (zh) | 2012-09-07 | 2024-07-05 | 瑞泽恩制药公司 | 以il-4r拮抗剂治疗特应性皮炎的方法 |
| JP7736667B2 (ja) | 2019-08-05 | 2025-09-09 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Ｉｌ－４ｒアンタゴニストを投与することによるアトピー性皮膚炎の治療方法 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2990420T (pt) | 2000-05-26 | 2017-03-16 | Immunex Corp | Uso de anticorpos de recetor de interleucina-4 e composições dos mesmos |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
| UA93653C2 (ru) | 2003-11-07 | 2011-03-10 | Иммунекс Корпорейшн | Выделенное антитело, kotopoe специфически связывается c человеческим рецептором il-4 (il-4r) |
| MX361174B (es) | 2003-12-23 | 2018-11-29 | Genentech Inc | Anticuerpos anti-il13 novedosos y sus usos. |
| US7501121B2 (en) | 2004-06-17 | 2009-03-10 | Wyeth | IL-13 binding agents |
| TWI307630B (en) | 2004-07-01 | 2009-03-21 | Glaxo Group Ltd | Immunoglobulins |
| AR050044A1 (es) | 2004-08-03 | 2006-09-20 | Novartis Ag | Anticuerpo especifico de il-4 |
| US20080044420A1 (en) | 2005-05-11 | 2008-02-21 | Heavner George A | Anti-IL-13 antibodies, compositions, methods and uses |
| EP2532677A1 (en) | 2005-10-21 | 2012-12-12 | Novartis AG | Human antibodies against il13 and therapeutic uses |
| CA2646626A1 (en) | 2006-03-22 | 2007-09-27 | Apogenix Gmbh | Antibody specific for human il-4 for the treatment of cancer |
| HUE052220T2 (hu) | 2006-09-08 | 2021-04-28 | Abbvie Bahamas Ltd | Interleukin-13 kötõfehérjék |
| CA2664343C (en) | 2006-10-02 | 2016-04-26 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human il-4 receptor |
| US7608693B2 (en) | 2006-10-02 | 2009-10-27 | Regeneron Pharmaceuticals, Inc. | High affinity human antibodies to human IL-4 receptor |
| EP2050764A1 (en) | 2007-10-15 | 2009-04-22 | sanofi-aventis | Novel polyvalent bispecific antibody format and uses thereof |
| TW200944231A (en) | 2007-11-30 | 2009-11-01 | Glaxo Group Ltd | Antigen-binding constructs |
| US8092804B2 (en) | 2007-12-21 | 2012-01-10 | Medimmune Limited | Binding members for interleukin-4 receptor alpha (IL-4Rα)-173 |
| GB0904214D0 (en) | 2009-03-11 | 2009-04-22 | Ucb Pharma Sa | Biological products |
| MX366337B (es) | 2010-10-06 | 2019-07-05 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti-receptor de interleucina-4 (il-4r). |
| PL2627673T3 (pl) | 2010-10-15 | 2018-01-31 | Medimmune Ltd | Terapie poprawiające funkcje płuc |
| CN118286417A (zh) * | 2012-09-07 | 2024-07-05 | 瑞泽恩制药公司 | 以il-4r拮抗剂治疗特应性皮炎的方法 |
| EP2981286A4 (en) | 2013-04-05 | 2016-08-24 | Hoffmann La Roche | ANTI-IL-4 ANTIBODIES AND BISPECIFIC ANTIBODIES AND USES THEREOF |
| EP2823841A1 (en) | 2013-07-09 | 2015-01-14 | Sanofi-Aventis Deutschland GmbH | Autoinjector |
| TW201711716A (zh) | 2015-06-03 | 2017-04-01 | 賽諾菲阿凡提斯德意志有限公司 | 護罩鎖 |
| TW201709941A (zh) | 2015-06-03 | 2017-03-16 | 賽諾菲阿凡提斯德意志有限公司 | 聲響指示器（二） |
| TW201707738A (zh) | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 注射器支架及自動注射器（二） |
| TW201711713A (zh) | 2015-06-03 | 2017-04-01 | 賽諾菲阿凡提斯德意志有限公司 | 藥物輸送裝置（五） |
| TW201707741A (zh) | 2015-06-03 | 2017-03-01 | 賽諾菲阿凡提斯德意志有限公司 | 針頭護罩之抓握器、蓋子、自動注射器及製造抓握器之方法 |
| CN107474134B (zh) | 2016-06-08 | 2021-07-27 | 苏州康乃德生物医药有限公司 | 用于结合白细胞介素4受体的抗体 |
| KR102330596B1 (ko) | 2018-11-09 | 2021-11-26 | 아주대학교산학협력단 | 인간 il-4 수용체 알파에 대한 고친화도 인간 항체 및 이의 용도 |
| CN111686247B (zh) | 2019-03-13 | 2022-07-29 | 苏州康乃德生物医药有限公司 | 包含人白介素-4受体α的抗体的液体组合物 |
| CN111592597B (zh) | 2019-05-29 | 2022-04-26 | 山东博安生物技术股份有限公司 | 白介素4受体(il-4r)结合蛋白及其用途 |
| KR20220158821A (ko) * | 2020-03-27 | 2022-12-01 | 리제너론 파아마슈티컬스, 인크. | Il-4r 길항제를 투여함에 의해 아토피 피부염을 치료하기 위한 방법 |
| CN113549151A (zh) | 2020-04-24 | 2021-10-26 | 苏州康乃德生物医药有限公司 | 与人IL-4Rα中特定表位结合的抗体及其应用 |
| WO2022052974A1 (en) | 2020-09-10 | 2022-03-17 | Staidson (Beijing) Biopharmaceuticals Co., Ltd. | Antibodies specifically recognizing interleukin-4 receptor alpha and uses thereof |
| EP4267614A1 (en) | 2020-12-23 | 2023-11-01 | Numab Therapeutics AG | Antibody variable domains that bind il-31 |
| EP4019547A1 (en) | 2020-12-23 | 2022-06-29 | Numab Therapeutics AG | Multispecific antibodies having specificity for il-4r and il-31 |
-
2022
- 2022-12-29 JP JP2024539527A patent/JP2025501239A/ja active Pending
- 2022-12-29 US US18/147,983 patent/US20230220089A1/en not_active Abandoned
- 2022-12-29 CA CA3241374A patent/CA3241374A1/en active Pending
- 2022-12-29 CN CN202280080525.3A patent/CN118355034A/zh active Pending
- 2022-12-29 MX MX2024006053A patent/MX2024006053A/es unknown
- 2022-12-29 AU AU2022425608A patent/AU2022425608A1/en active Pending
- 2022-12-29 KR KR1020247025561A patent/KR20240135618A/ko active Pending
- 2022-12-29 WO PCT/US2022/082535 patent/WO2023130010A1/en not_active Ceased
- 2022-12-29 EP EP22854747.7A patent/EP4457245A1/en active Pending
- 2022-12-29 IL IL313897A patent/IL313897A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022543612A5 (enExample) | ||
| US20240199751A1 (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| CN105517570B (zh) | 通过施用il-4r拮抗剂治疗鼻息肉症的方法 | |
| JP2025172841A5 (enExample) | ||
| JP2021523188A5 (enExample) | ||
| JP2023520676A5 (enExample) | ||
| JP2022543815A5 (enExample) | ||
| TW202106334A (zh) | 藉由投予ｉｌ－３３拮抗劑治療或預防哮喘之方法 | |
| JP2024502471A5 (enExample) | ||
| JP2020100653A (ja) | ベンラリツマブによる喘息症状の改善方法 | |
| JP2024532263A5 (enExample) | ||
| CN115697378A (zh) | 用cgrp抑制剂治疗肺部损伤的方法 | |
| JP2023531968A5 (enExample) | ||
| CN118355034A (zh) | 施用il-4/il-13拮抗剂以减弱特应性进程的方法 | |
| TW202206457A (zh) | 用於治療呼吸疾病之泛elr+ cxc趨化因子抗體 | |
| RU2024121393A (ru) | Способы ослабления атопического марша посредством введения антагониста il-4/il-13 | |
| RU2024107446A (ru) | Способы лечения атопического дерматита посредством введения антагониста il-4r | |
| JP6923594B2 (ja) | Ｉｌ−４ｒアンタゴニストを投与することにより喘息を処置又は予防するための方法 | |
| RU2022105374A (ru) | Способы лечения атопического дерматита посредством введения антагониста il-4r | |
| RU2020140639A (ru) | Способы лечения атопического дерматита посредством введения ингибитора ил-4r | |
| HK40076109A (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| HK40076109B (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| WO2025214333A1 (zh) | 抗tslp抗体治疗与tslp相关的炎症疾病的方法 | |
| HK40106058A (en) | Methods for treating or preventing asthma by administering an il-4r antagonist | |
| WO2024077113A1 (en) | Methods of treating fatigue in ulcerative colitis |